FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to a method for producing a tablet that releases the active ingredient glucocorticoid at a preset place of the gastrointestinal tract. The above method involves determining a place of the gastrointestinal tract, to which glucocorticoid is supposed to be delivered; forming a coated tablet with a core containing glucocorticoid and a swelling adjuvant, and a non-swelling and nonerodable inert coating; and pressing the coating of the above tablet at a pressure specified so as to cause a release of glucocorticoid at the above preset place. The invention also refers to the tablet prepared by the above method and using it for treating inflammatory diseases.
EFFECT: invention provides a drug delivery system for releasing the active ingredient glucocorticoid in the target intestinal departments notwithstanding the food ingestion.
41 cl, 5 dwg, 7 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
TABLETS WITH ACTIVE INGREDIENT RELEASE WHICH TAKES PLACE IN SPECIFIED PLACE AT SPECIFIED TIME | 2005 |
|
RU2435568C2 |
SLOW-RELEASE TABLET WITH SPECIFIED CORE GEOMETRY | 2004 |
|
RU2391093C2 |
TACROLIMUS FOR IMPROVED TREATMENT OF PATIENTS WITH GRAFTS | 2009 |
|
RU2574006C2 |
PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF HELICOBACTER PYLORI | 2014 |
|
RU2671400C2 |
METHODS OF TREATING GASTROINTESTINAL TRACT DISORDERS INDEPENDENTLY ON FOOD CONSUMPTION | 2014 |
|
RU2563993C1 |
FORMULATIONS OF LORAZEPAM WITH SUSTAINED RELEASE | 2014 |
|
RU2678324C2 |
ORAL RIFAMYCIN SV COMPOSITIONS | 2018 |
|
RU2793319C2 |
MODIFIED RELEASE PHARMACEUTICAL COMPOSITION CONTAINING FEBUXOSTAT | 2011 |
|
RU2602188C2 |
DELAYED FIXED-TIME PULSATILE RELEASE DOSAGE FORMS | 2008 |
|
RU2452472C2 |
MEDICINAL FORM FOR PERORAL INJECTION AT DELAYED IMMEDIATE RELEASE AND METHOD FOR ITS PREPARATION | 1997 |
|
RU2193395C2 |
Authors
Dates
2016-03-10—Published
2005-09-09—Filed